Long-acting glucagon-like peptide-1 receptor agonist-status December 2018

被引:16
作者
Holst, Jens Juul [1 ,2 ]
机构
[1] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-220 Copenhagen, Denmark
[2] Univ Copenhagen, Panum Inst, NNF Ctr Basic Metab Res, DK-220 Copenhagen, Denmark
关键词
BETA-CELL FUNCTION; GLP-1; RECEPTOR; CARDIOVASCULAR OUTCOMES; HEART-FAILURE; DOUBLE-BLIND; FOOD-INTAKE; TYPE-2; LIRAGLUTIDE; GLUCOSE; SEMAGLUTIDE;
D O I
10.21037/atm.2019.01.09
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative Outcomes
    Aschen, Seth Z.
    Zhang, Ashley
    O'Connell, Gillian M.
    Salingaros, Sophia
    Andy, Caroline
    Rohde, Christine H.
    Spector, Jason A.
    ANNALS OF SURGERY, 2025, 281 (04) : 600 - 607
  • [22] Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist
    Parker, Victoria E. R.
    Robertson, Darren
    Wang, Tao
    Hornigold, David C.
    Petrone, Marcella
    Cooper, Aidan T.
    Posch, Maximilian G.
    Heise, Tim
    Plum-Moerschel, Leona
    Schlichthaar, Heike
    Klaus, Beate
    Ambery, Philip D.
    Meier, Juris J.
    Hirshberg, Boaz
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03) : 803 - 820
  • [23] The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution
    Zhao, Li
    Zhu, Chunfang
    Lu, Meng
    Chen, Chi
    Nie, Xiaomin
    Abudukerimu, Buatikamu
    Zhang, Kun
    Ning, Zhiyuan
    Chen, Yi
    Cheng, Jing
    Xia, Fangzhen
    Wang, Ningjian
    Jensen, Michael D.
    Lu, Yingli
    JOURNAL OF ENDOCRINOLOGY, 2019, 240 (02) : 271 - 286
  • [24] Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
    Underwood, Christina Rye
    Garibay, Patrick
    Knudsen, Lotte Bjerre
    Hastrup, Sven
    Peters, Gunther H.
    Rudolph, Rainer
    Reedtz-Runge, Steffen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (01) : 723 - 730
  • [25] Glucagon-Like Peptide-1 Receptor Agonist Administration Suppresses Both Water and Saline Intake in Rats
    McKay, N. J.
    Daniels, D.
    JOURNAL OF NEUROENDOCRINOLOGY, 2013, 25 (10) : 929 - 938
  • [26] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05) : 788 - 805
  • [27] Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
    Glaesner, Wolfgang
    Vick, Andrew Mark
    Millican, Rohn
    Ellis, Bernice
    Tschang, Sheng-Hung
    Tian, Yu
    Bokvist, Krister
    Brenner, Martin
    Koester, Anja
    Porksen, Niels
    Etgen, Garret
    Bumol, Tom
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (04) : 287 - 296
  • [28] The Glucagon-Like Peptide-1 Receptor-or Not?
    Pyke, Charles
    Knudsen, Lotte Bjerre
    ENDOCRINOLOGY, 2013, 154 (01) : 4 - 8
  • [29] Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?
    Holst, Jens Juul
    LANCET, 2019, 394 (10192) : 4 - 6
  • [30] Sleep is increased by liraglutide, a glucagon-like peptide-1 receptor agonist, in rats
    Fang, Jidong
    Miller, Patti
    Grigson, Patricia S.
    BRAIN RESEARCH BULLETIN, 2023, 192 : 142 - 155